Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 1
2018 3
2019 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation.
Lorente L, Rodriguez ST, Sanz P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA. Lorente L, et al. Among authors: diaz d. World J Hepatol. 2022 Jun 27;14(6):1182-1189. doi: 10.4254/wjh.v14.i6.1182. World J Hepatol. 2022. PMID: 35978670 Free PMC article.
Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations.
Lorente L, Rodriguez ST, Sanz P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA. Lorente L, et al. Among authors: diaz d. World J Clin Cases. 2023 Mar 16;11(8):1753-1760. doi: 10.12998/wjcc.v11.i8.1753. World J Clin Cases. 2023. PMID: 36970008 Free PMC article.
High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation.
Lorente L, Rodriguez ST, Sanz P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA. Lorente L, et al. Among authors: diaz d. Expert Rev Mol Diagn. 2019 Jul;19(7):635-640. doi: 10.1080/14737159.2019.1619549. Epub 2019 May 20. Expert Rev Mol Diagn. 2019. PMID: 31084510
Serum total antioxidant capacity prior to liver transplantation for hepatocellular carcinoma is associated with 1-year liver transplantation survival.
Lorente L, Rodriguez ST, Sanz P, Pérez-Cejas A, Abreu-González P, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Barrera MA. Lorente L, et al. Among authors: diaz d. J Int Med Res. 2018 Jul;46(7):2641-2649. doi: 10.1177/0300060518768150. Epub 2018 Jun 18. J Int Med Res. 2018. PMID: 29911482 Free PMC article.
Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver Transplantation.
Lorente L, Rodriguez ST, Sanz P, Abreu-González P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA. Lorente L, et al. Among authors: diaz d. Int J Mol Sci. 2019 Apr 5;20(7):1696. doi: 10.3390/ijms20071696. Int J Mol Sci. 2019. PMID: 30959735 Free PMC article.
Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality.
Lorente L, Rodriguez ST, Sanz P, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Barrera MA. Lorente L, et al. Among authors: diaz d. Oncotarget. 2018 Apr 20;9(30):21552-21559. doi: 10.18632/oncotarget.25097. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765559 Free PMC article.